Table 1.
Comparison of anti‐Hp antibody positive rate, CA724, CA19‐9, and CEA levels among three groups
| Groups | Young patients with early gastric cancer (n = 200) | Gastritis (n = 206) | Healthy subjects (n = 204) | F/χ2 | P |
|---|---|---|---|---|---|
| CA724 (U/mL) | 2.36 ± 1.61 | 0.59 ± 0.29* | 0.53 ± 0.34* | F = 5.675 | .003 |
| CA19‐9 (U/mL) | 34.09 ± 15.24 | 16.32 ± 9.13* | 15.87 ± 6.01* | F = 7.126 | <.001 |
| CEA (ng/mL) | 1.65 ± 1.08 | 0.71 ± 0.33* | 0.66 ± 0.40* | F = 4.009 | .019 |
| Anti‐Hp antibody | |||||
| Positive | 156 | 96* | 83*, # | χ2 = 65.482 | <.001 |
| Negative | 44 | 110* | 121*, # | ||
Abbreviations: CA724, carbohydrate antigen‐724; CEA; carcinoembryonic antigen; CA19‐9, carbohydrate antigen 19‐9.
*
Compared with gastric cancer, P < .05;
#
Compared with gastritis, P < .05.